News & Events
News
LaVoieHealthScience Announces Appointment of Nick Hennen as Head of Media, Boston, Building Out Media Training for Staff and Clients
BOSTON & NEW YORK, Wednesday, November 9, 2022–LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today...
LaVoieHealthScience Bolsters Commercial Strategic Communications Expertise with the Hiring of Deborah Plumstead as Vice President
BOSTON & NEW YORK, August 16, 2022–LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced...
LaVoieHealthScience Announces Continuance of U.S. Service Marks for LHS Immersion® and The LHS Fifteen-Slide Presentation®
Proprietary Message & Positioning Platform Defines Narrative for Health & Science Innovators USPTO recognizes continued use of proprietary professional services, grants exclusive...
LaVoieHealthScience Announces Appointment of Gemma Bakx as Senior Vice President of Investor Relations and Financial Communications
Further Strengthens IR Leadership Team and Supports Integrated Strategic Communications Capabilities and Continued Business Growth...
Events
Our event calendar includes select industry, medical and investor conferences that LHS and clients will attend throughout the year.
LaVoieHealthScience Blog
Top 5 Communications Strategies in Turbulent Times
During these times of rapid change, it is increasingly important to strengthen one’s ability to adapt and communicate under pressure. Your company’s ability to communicate is the difference between...
The Importance of Natural History Data for Clinical Trial Development in Rare and Orphan Diseases
The return of in-person conferences coming back to Boston is great to see. The late Summer and early Fall have been busy with the very well-attended 42nd Canaccord Genuity Growth Conference in...
Back to BIO In Person: An Interview with Donna LaVoie, President & CEO
by Gemma Bakx, SVP, Investor Relations and ESG GB: Donna, you have been presenting How to Tell Your Company Story in 15 Slides at the Biotechnology Innovation Organization International Convention...
Managing Turbulent Times and the Integrated Communication Model
An Interview with Gemma Bakx, head of Investor Relations and ESG at LaVoieHealthScience by Paul Sagan, VP, Investor Relations and Corporate Communications PS: What led to your investor relations...